October 29, 2024 Maria Dranishnikova ‘Patriotic marketplace’ stock surges after additional share issue, payments platform launch
October 28, 2024 Maria Dranishnikova The Motley Fool highlights two small caps with ‘far more’ upside than the Magnificent Seven
October 28, 2024 Maria Dranishnikova Royce Premier Fund reveals biggest third-quarter contributing and detracting stocks
October 25, 2024 Maria Dranishnikova Spirit Airlines caps off big week with gains on announcement of aircraft sale
October 25, 2024 Maria Dranishnikova EF Hutton sees over 600% upside in biotech small cap ImmunityBio
October 25, 2024 Maria Dranishnikova Third time’s the charm: How Achieve Life Sciences developed a breakthrough drug for vaping addiction
October 25, 2024 Viktoriya Sirota Potential Eli Lilly and Novo Nordisk competitor surges 21% on third-quarter financials
October 24, 2024 Maria Dranishnikova La Rosa Holdings doubles market capitalization on upbeat preliminary nine-month financials
October 23, 2024 Maria Dranishnikova Low-cost carrier Spirit soars on revived merger talks with Frontier
October 22, 2024 Maria Dranishnikova Heart monitor maker iRhythm surges after FDA approval for design changes
October 22, 2024 Maria Dranishnikova Playboy Group stock soars after founder’s son makes offer to buy back the brand
October 21, 2024 Maria Dranishnikova Spirit Airlines soars 40% after debt refinancing extension granted
October 21, 2024 Maria Dranishnikova Morgan Stanley spotlights 10 small-cap stocks with at least 50% upside
October 18, 2024 Maria Dranishnikova Kidney disease drug developer XORTX slides after direct offering announced
October 17, 2024 Maria Dranishnikova Freedom Finance analyst highlights two small caps for risk-tolerant investors
October 17, 2024 Viktoriya Sirota Nuclear energy stocks soar after Amazon backs advanced reactor technology
October 16, 2024 Maria Dranishnikova Weight-loss market innovator Lexaria Bioscience drops after direct offering announced
October 15, 2024 Maria Dranishnikova Pickup in M&A activity bodes well for small caps — Jefferies analyst